Most common cancer in women
Pro Research Analysisby 
Searched over 200M research papers
Most Common Cancer in Women: Breast Cancer
Breast Cancer Incidence and Mortality
Global Prevalence of Breast Cancer
Breast cancer is the most common cancer among women worldwide, accounting for a significant portion of new cancer diagnoses each year. It is prevalent in both developed and developing regions, making it a global health concern Bray2004Michailidou2013Harbeck2019. The incidence of breast cancer has been rising over the past few decades, with more than 2 million new cases diagnosed annually Yi2021Łukasiewicz2021.
Mortality Rates
Breast cancer is also the leading cause of cancer-related deaths among women globally. Despite advancements in treatment and early detection, the mortality rate remains high, particularly in regions with limited access to healthcare resources Bray2004Lodi2017Yi2021. The survival rates vary significantly by region, with higher survival rates in developed countries compared to developing ones .
Risk Factors and Genetic Susceptibility
Genetic Factors
Several genetic factors contribute to the risk of developing breast cancer. Variants at multiple loci have been identified, accounting for a portion of the familial risk associated with the disease. Studies have identified numerous single nucleotide polymorphisms (SNPs) that are linked to increased susceptibility to breast cancer Michailidou2013Wooster2003. Additionally, mutations in genes such as BRCA1 and BRCA2 are well-known risk factors Harbeck2019Zhu2023.
Age and Other Risk Factors
Age is a significant risk factor for breast cancer, with the majority of cases occurring in women over the age of 50. Other risk factors include hormonal influences, reproductive history, and lifestyle factors such as diet and physical activity Lodi2017Łukasiewicz2021. Younger women, although less frequently diagnosed, tend to have more aggressive forms of the disease and face unique challenges related to fertility and psychosocial aspects .
Clinical Characteristics and Treatment
Molecular Subtypes
Breast cancer is a heterogeneous disease with various molecular subtypes, including Luminal A, Luminal B, HER2-enriched, and basal-like. These subtypes are determined based on gene expression profiles and have distinct prognostic and therapeutic implications Harbeck2019Łukasiewicz2021. Treatment strategies are tailored according to these molecular characteristics, involving a combination of surgery, radiation, chemotherapy, hormonal therapy, and targeted biological therapies .
Treatment and Management
Management of breast cancer is multidisciplinary, involving locoregional treatments such as surgery and radiation, as well as systemic therapies. Advances in treatment have significantly improved outcomes, particularly for early-stage, non-metastatic disease. However, advanced breast cancer with distant metastases remains incurable with current therapies Harbeck2019Łukasiewicz2021.
Epidemiological Trends and Survival Rates
Trends Over Time
The incidence and mortality rates of breast cancer have shown geographical and temporal variations. In developed regions, the incidence has increased partly due to better cancer detection and registration, while mortality rates have decreased due to improved treatment and early detection Bray2004Yi2021. In contrast, developing regions face rising incidence and mortality rates, highlighting the need for better healthcare infrastructure and access to treatment Yi2021Maajani2019.
Survival Rates
Survival rates for breast cancer have improved over recent decades, with global 1-, 3-, 5-, and 10-year survival rates showing significant variation. These rates are higher in developed countries compared to developing ones, reflecting disparities in healthcare access and quality . Efforts to improve early detection and treatment access are crucial for enhancing survival outcomes worldwide.
Conclusion
Breast cancer remains the most common and deadly cancer among women globally. While significant progress has been made in understanding its genetic basis, risk factors, and treatment, disparities in incidence, mortality, and survival rates persist. Continued research and equitable access to healthcare are essential to combat this pervasive disease effectively.
Sources and full results
Most relevant research papers on this topic